1
Assessment of 5-Aminosalicylic Acid Prescription Patterns and Treatment Outcomes in Patients With Ulcerative Colitis in Korea
Condition(s):Ulcerative ColitisLast Updated:May 26, 2022Recruiting
Pentasa: 289 Clinical Trials, Page 1 of 29
Hide Studies Not Open or Pending
2
Canadian Active & Maintenance Modified Pentasa Study
Condition(s):Active Ulcerative Colitis; Remission of Ulcerative ColitisLast Updated:April 22, 2016Completed
3
The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study
Condition(s):Irritable Bowel SyndromeLast Updated:December 31, 2020Completed
4
A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis
Condition(s):Ulcerative Colitis (UC)Last Updated:May 23, 2022Not yet recruiting
5
Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection
Condition(s):HIV-1-infection; Gut InflammationLast Updated:March 4, 2020Completed
6
Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis
Condition(s):Ulcerative ColitisLast Updated:February 12, 2016Completed
7
Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS)
Condition(s):Irritable Bowel SyndromeLast Updated:February 12, 2014Completed
8
Use of Rectal Dialysis Technique to Measure Rectal 5-ASA Levels in Healthy Volunteers Receiving Asacol
Condition(s):Ulcerative ColitisLast Updated:October 15, 2019Terminated
9
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
Condition(s):Lynch Syndrome; Colon Cancer; Colon NeoplasmLast Updated:March 28, 2022Recruiting
10
Correlation of Mesalamine Pharmacokinetics With Local Availability
Condition(s):Local Drug Concentration in Gastrointestinal TractLast Updated:May 15, 2017Completed